1. Introduction {#sec1}
===============

Herbal medicines are valuable and available resources of primary health care for thousands year in the traditional medicine including the Thai folk medicine. Generally, the bioactive compounds in herbal medicines are secondary metabolites which act as various pharmacological properties.[@bib1], [@bib2], [@bib3] They are used as the substances of modern drugs e.g. morphine from *Papaver somniferum* for pain treatment,[@bib4], [@bib5] colchicine from *Colchicum autumnale* for treatment in pericardial disease.[@bib6] Some studies have reported antibacterial activity from various herbs[@bib7], [@bib8], [@bib9]; however, sufficient evidence to support their active compounds and their effectiveness for antibacteria and antibiofilm, particularly on oral pathogens is limited.

An imbalance of bacteria in the dental biofilm can cause dental caries and periodontitis which are major oral infections.[@bib10] The high doses of antimicrobial agents are need for removing the biofilm in clinical approach.[@bib11], [@bib12] Moreover, in long term use of chlorhexine (CHX) mouth-rinse can cause side effects; disturbance in taste sensation, brown discoloration at dorsum of tongue and desquamative lesions of oral mucosa.[@bib13], [@bib14]

Our previous study has presented anticandidal and antibiofilm of some Thai herbs in Thailand.[@bib15] All herbs tested were commonly found in tropical areas of Southeast Asia. Herbal medicines may be an alternative way for being antibacterial agents to prevent oral infectious diseases. This extended study was to evaluate the antibacterial and antibiofilm activities of 12 ethanol extracts of Thai traditional herb included *Alpinia galanga*, *Curcuma longa*, *Curcuma zedoaria*, *Piper betle*, *Piper chaba*, *Piper nigrum*, *Piper sarmentosum*, *Mentha cordifolia*, *Ocimum africanum*, *Ocimum basilicum*, *Ocimum sanctum* and *Zingiber officinale*, and to investigate the active compounds of the most effective extract.

2. Materials and methods {#sec2}
========================

2.1. Preparation of medicinal herb extracts {#sec2.1}
-------------------------------------------

Twelve herbs were purchased from the local market, and the details were shown in [Table 1](#tbl1){ref-type="table"}. The herbs were identified by an expert in the Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla, Thailand, where voucher specimens ([Table 1](#tbl1){ref-type="table"}) were deposited in the herbarium. Dried plants were macerated with ethanol for 3 days, and then filtrated through Whatman No. 4 filter paper. Each filtrate was dried using a rotary evaporator at 40 °C and kept at −20 °C. For testing, 0.1 mg of each dried extract was initially dissolved with 100 μL of dimethyl sulfoxide (DMSO) and then adjusted to 1 mL by adding sterile distilled water, giving a final concentration of 10% (w/v) extract in 10% (v/v) dimethyl sulfoxide (DMSO).

2.2. Bacterial strains and growth conditions {#sec2.2}
--------------------------------------------

A total of 7 oral microorganisms were employed in the study including 5 Gram positive cariogenic bacteria, *Enterobacter faecalis* ATCC 19433 (*Ef*), *Lactobacillus fermentum* ATCC 14931 (*Lf*), *Lactobacillus salivarius* ATCC 11741 (*Ls*), *Streptococcus sobrinus* ATCC 33478 (*Ss*) and *Streptococcus mutans* ATCC 25175 (*Sm*), and 2 Gram negative periodontopathogenic bacteria, *Aggregatibacter actinomycetemcomitans* ATCC 33384 (*Aa*) and *Fusobacterium nucleatum* ATCC 25586 (*Fn*). Microorganisms were maintained on either brain heart infusion agar (BHA) with 5% (v/v) blood for facultative bacteria, and supplemented with 0.5% (w/v) yeast extract, hemin and vitamin K for anaerobic bacteria. The strains were grown under aerobic or anaerobic (10% H~2~, 10% CO~2~ and 80% N~2~) conditions as appropriate.

2.3. Antibacterial assay {#sec2.3}
------------------------

### 2.3.1. Agar well diffusion method {#sec2.3.1}

One hundred microliters of inoculum, equivalent to 10^7^ CFU/mL, was mixed with 20 mL of warm melted BHA. The mixture was then poured into the plate with a 6 mm diameter metal cup. After solidifying of BHA, the metal cups were removed and the well was added with 100 μL of each plant extract. The plate was incubated at 37 °C for 24 h. A 10% DMSO were taken as a negative control. The antimicrobial activity of each plant extract was determined by measuring the diameter of the zone of the inhibition in millimeters. Duplicates were maintained and the experiment was repeated thrice.

### 2.3.2. Broth microdilution method {#sec2.3.2}

Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were carried out as recommended instruction of the Clinical and Laboratory Standards Institute (CLSI). Briefly, 10% stock solution of each extract was diluted in the brain heart infusion broth (BHI) in two-fold serial dilutions to obtain concentrations from 0.02 to 25 mg/mL at a total volume of 100 μL per well in 96-well microtiter plates. Each tested strain (100 μL) at a final concentration of 1 × 10^6^ CFU/mL was added to each well and incubated at 37 °C in appropriate conditions. The medium, 0.1% (w/v) CHX and 10% DMSO were used as the non-treated, positive and negative controls, respectively.

MIC was defined as the lowest concentration of the extract that completely inhibited growth in comparison with the non-treated control. MBC was defined as the lowest concentration of wells that did not allow visible growth when 10 μL of the well contents was plated on agar and grown at 37 °C in appropriate conditions. All experiments were repeated thrice in duplicate.

### 2.3.3. Time-kill assay {#sec2.3.3}

As the results of the screening of herb extracts revealed that *P. betle* leaves extract gave the strongest antibacterial activity. Thus, *P. betle* extract was used for the time-kill assay. The growing cultures (10^6^ CFU/mL) of representative strains, *S. mutans* ATCC 25175 and *A. actinomycetemcomitans* ATCC 33384, were incubated in BHI broth supplemented with the extract at concentrations equivalent to 1 ×, 2 ×, and 4 × MIC at 37 °C. Surviving bacteria were observed at 0, 0.5, 1, 2, 4, 6, 8, 10, 12 and 24 h by culturing on agar plates. The procedure was repeated in triplicate, and the log~10~ CFU/mL was plotted against time. A 0.1% CHX and extract free medium were used as positive and non-treated controls, respectively.

2.4. Antibiofilm assay {#sec2.4}
----------------------

### 2.4.1. Inhibition of biofilm formation {#sec2.4.1}

The effect of *P. betle* extract on biofilm formation of each representative strain, *S. mutans* ATCC 25175 and *A. actinomycetemcomitans* ATCC 33384, was examined by using the modified microdilution method.[@bib16] Briefly, two-fold serial dilutions of *P. betle* extract were prepared, with final concentration ranged from 0.02 to 25 mg/mL. A cell suspension of the tested strains was prepared as described in the MIC assay, and 100 μL (1 × 10^6^ CFU/mL) were inoculated in each of a 96-well plate. A 0.1% CHX, phosphate buffered saline (PBS) and extract free medium were used as the positive controls, non-treated and blank controls, respectively. After incubation at 37 °C for 24 h, supernatants were discarded and washed 3 times with PBS. Biofilm formation was quantified by using a 3-\[4,5-dimethyl-2-thiazolyl\]-2, 5-diphenyl-2H-tetrazolium-bromide (MTT) assay. The numbers of surviving bacteria were determined by measuring their ability to reduce the yellow tetrazolium salt to a purple formazan product at 570 nm. Higher OD values indicate an increased number of surviving microorganisms in the biofilm. Percentage inhibition was calculated by using the equation \[1 − (A~570~ of the test/A~570~ of non-treated control)\] × 100. The minimum biofilm inhibition concentration (MBIC) was defined as the lowest concentration that showed 50% and 90% inhibition of biofilm formation (MBIC~50~ and MBIC~90~).

### 2.4.2. Eradication of biofilm formation {#sec2.4.2}

The eradication of biofilm formation of *P. betle* extract was also examined using the minimum biofilm eradication concentration (MBEC) assay. Briefly, a 200 μL in early log phase (10^6^ CFU/mL) of each representative strain, *S. mutans* ATCC 25175 and *A. actinomycetemcomitans* ATCC 33384, was inoculated into each well of a 96-well plate and incubated for 24 h at 37 °C for the development of a multilayer biofilm. The culture was then blotted out, and the well carefully washed 3 times with sterile PBS in order to remove non-adherent cells.[@bib16] These biofilms were then exposed to a 200 μL of various concentrations of *P. betle* extract ranged from 0.02 to 25 mg/mL, incubated for 24 h at 37 °C in appropriate conditions. At the end-point of the treatment of the biofilms with *P. betle* extract, the adherent cells were washed 3 times with sterile PBS. The numbers of surviving culture were determined using MTT assay. Percentage eradication was calculated by using the equation \[1 − (A~570~ of the test/A~570~ of non-treated control)\] × 100. The MBEC value was defined as the concentrations that showed 50% and 90% eradication of biofilm formation. The 0.1% CHX, PBS and the extract free medium were used as the positive, non-treated and blank controls, respectively.

2.5. Bioactive compound assay {#sec2.5}
-----------------------------

### 2.5.1. High performance liquid chromatography (HPLC) {#sec2.5.1}

The active antibacterial compounds of *P. betle* extract were analyzed using the high performance liquid chromatography (HPLC) (Agilent^®^ 1100 series, Palo Alto, CA). The reverse column was Apollo C18, 250 mm × 4.6 mm, 5 μm particle size (Alltech Associates Inc., Deerfield, IL). The conditions were set as following; mobile phases (methanol:water 70:30 v/v), flow rate at 0.7 mL/min and UV detector at 280 nm. A injection volume (20 μL) of each sample, 1 mg of *P. betle* extract, 5 μL of pure eugenol (the agent controller) and 0.5 mg of 4-chromanol (the agent controller), were prepared in 1 mL of 95% (v/v) ethanol. Each prepared sample was taken to analyze by HPLC, and curves were prepared using the Microsoft Excel software package (Excel 2007; Microsoft Corporation, Redmond, WA, USA). The experiments were performed three times.

### 2.5.2. Thin layer chromatography (TLC) fingerprinting and TLC-bioautography of *P. betle* extract {#sec2.5.2}

For TLC-fingerprinting study, 100 mg of *P. betle* extract, 5 μL of pure eugenol (the agent controller) and 1 mg of 4-chromanol (the agent controller) were prepared in 1 mL of 95% ethanol. A 10 μL of each sample was applied onto the alumina silica gel GF~254~ TLC-plate, and was run through a series of solvent systems using a mixture of toluene and ethyl acetate (90:10 v/v) as the mobile phase. The plate was air dried, and was stained with a 20% (w/v) of phosphomolybdic acid in ethanol.[@bib17]

TLC-bioautography was performed using agar overlay method. TLC-plates were placed on plate contained 6 mL of BHA, and 10 mL of top agar with 100 μL of either *S. mutans* ATCC 25175 or *A. actinomycetemcomitans* ATCC 33384 inoculum (10^7^ CFU/mL) was covered on TLC plate. After overnight incubation, the inhibited zone was observed as clear zone. The relative front values (R~f~) was calculated as: R~f~ = distance traveled by solute/distance traveled by solvent.[@bib18]

2.6. Statistical analysis {#sec2.6}
-------------------------

Data were expressed as mean and standard deviation (SD) by computational analysis from the three experiments with duplicate or triplicate independent experiments.

3. Results {#sec3}
==========

3.1. Effect of Thai medicinal plants against bacteria {#sec3.1}
-----------------------------------------------------

Antibacterial activity of 12 Thai traditional herb extracts against various oral bacteria was revealed in [Table 1](#tbl1){ref-type="table"}. The different extracts showed different inhibited zone ranged from 1 to 20 mm. *P. betle* leaves showed a good result of antibacterial activity against all tested microorganisms using agar well diffusion assay ([Table 1](#tbl1){ref-type="table"}). The MIC of *P. betle* extract ranged from 1.04 to 5.21 mg/mL and MBC ranged from 2.08 to 8.33 mg/mL, respectively ([Table 2](#tbl2){ref-type="table"}).

3.2. Time-kill assay of *P. betle* against bacteria {#sec3.2}
---------------------------------------------------

Time kill assay of *P. betle* extract against representative strains, *S. mutans* ATCC 25175 and *A. actinomycetemcomitans* ATCC 33384, is demonstrated in [Fig. 1](#fig1){ref-type="fig"}. It was depended on time and concentrations of the extract. The completed killing of *S. mutans* ATCC 25175 treated with 1 ×, 2 ×, and 4 × MIC of the extract occurred within 12, 8, and 6 h, respectively. At 1 ×, 2 ×, and 4 × MIC, *A. actinomycetemcomitans* ATCC 33384 was killed after 6, 2, and 1 h, respectively. The killing of positive control (0.1% CHX) was observed within 30 min.

The present study demonstrated that commonly used Thai herbs could exhibit antimicrobial activity against various oral bacteria. Of 12 Thai traditional herb extracts, *P. betle* extract revealed the best antibacterial activity against both Gram positive bacteria and Gram negative bacteria.

3.3. Effect of *P. betle* extract on inhibition and eradication biofilm formation {#sec3.3}
---------------------------------------------------------------------------------

The inhibition and eradication of the biofilm formation of *P. betle* extract against *S. mutans* ATCC 25175 and *A. actinomycetemcomitans* ATCC 33384 is demonstrated in [Fig. 2](#fig2){ref-type="fig"}a and b, respectively. The concentrations of *P. betle* extract required to inhibit for ≥50% biofilm formation (MBIC~50~) of *S. mutans* ATCC 25175 and *A. actinomycetemcomitans* ATCC 33384 were 0.39 ± 0.20 and 0.10 ± 0.03 mg/mL, respectively. And for ≥90% biofilm inhibitions (MBIC~90~) were 1.56 ± 0.11 and 0.39 ± 0.65 mg/mL, respectively. The concentrations of *P. betle* extract to eradicate for ≥50% biofilm formation (MBEC~50~) of *S. mutans* ATCC 25175 and *A. actinomycetemcomitans* ATCC 33384 were 0.78 ± 0.74 and 0.78 ± 0.11 mg/mL, respectively. And for ≥90% biofilm eradication (MBEC~90~) were 6.25 ± 0.58 and 3.13 ± 0.28 mg/mL, respectively. CHX could completely (100%) inhibit or remove biofilm formation of both tested strains.

3.4. HPLC and TLC analysis {#sec3.4}
--------------------------

Due to its interesting results, the further study focused on the active compounds of *P. betle* leaves extract. The HPLC chromatograms of the standards, 4-chromanol and eugenol ([Fig. 3](#fig3){ref-type="fig"}a), *P. betle* extract ([Fig. 3](#fig3){ref-type="fig"}b) and the mixture of *P. betle* extract and the standards ([Fig. 3](#fig3){ref-type="fig"}c) are shown. Peak 1 of [Fig. 3](#fig3){ref-type="fig"}a--c was identified as 4-chromanol with retention times of 5.486 ± 0.00 min, 5.654 ± 0.04 min and 5.610 ± 0.00 min, respectively. Peak 2 of [Fig. 3](#fig3){ref-type="fig"}a--c was eugenol with retention times of 7.853 ± 0.01 min, 7.966 ± 0.09 min and 7.757 ± 0.01 min, respectively. It indicated that at least 4-chromanol and eugenol were the components of *P. betle* leaves extract.

There were several bands of *P. betle* extract components appeared on the TLC-plate ([Fig. 4](#fig4){ref-type="fig"}a). One major band with R~f~ at 0.38 matched to the standard 4-chromanol gave the large inhibited clear zone against *S. mutans* ATCC 25175 in TLC-bioautography assay ([Fig. 4](#fig4){ref-type="fig"}b), and this band also gave inhibited clear zone against *A. actinomycetemcomitans* ATCC 33384 (data not shown). Another minor band with R~f~ at 0.74 matched to the standard eugenol did not show any inhibited zone.

4. Discussion {#sec4}
=============

*P. betle* (family Piperaceae) is known as "Phlu", which has been extensively used in traditional herbal remedies in Thailand and many other countries in tropical Asia. It is reported having various pharmacological activities such as antimicrobial, immunomodulatory, and anti-inflammatory.[@bib19] A significant antimicrobial activity against a wide range of medical bacteria such as *Streptococcus pyogenes*, *Staphylococcus aureus*, *Proteus vulgaris*, *Escherichia coli*, *Pseudomonas aeruginosa* etc. was found in the leaves.[@bib20] In this study, it has shown that *P. betle* extract also exhibited antimicrobial activity against various oral microorganisms including cariogenic and periodontogenic pathogens e.g. *S. mutans* and *A. actinomycetemcomitans*. Our results agree with the study of Deshpande and Kadam[@bib21] who demonstrated the finding of antibacterial activity of ethanol and aqueous crude extract of *P. betle* leaves against *S. mutans*. In that report, zone of inhibition of ethanol extract (20.6 ± 1.12 mm) was found to be larger than aqueous extract (18.3 ± 0.53 mm). The MIC value for the aqueous and ethanol extract was 10 mg/mL and 5 mg/mL, respectively. The *P. betle* leaves ethanol extract in this study was found to be more potent with MIC value of 1.56 mg/mL. This may be due to ecological and geographical conditions, age of herb and time of harvesting. However, there was no information of antibiofilm was mentioned in that study.

The antibiofilm is a desired property that expected from herbs extracts. In this study, *P. betle* leaves extract has been revealed having dual actions in preventing and eradicating biofilm formation. It may be worth for considering the *P. betle* leaves extracts to replace CHX mouth-rinse. CHX is a chemical-based antimicrobial agent which is used extensively in the mouth-rinse to maintain dental biofilm at a level compatible with oral health. However, it was reported on some undesired local side effects for long term use.[@bib13], [@bib14]

Results of both planktonic and biofilm form indicated that *P. betle* extract was more active against Gram negative bacteria than Gram positive bacteria. The similar results were also reported in *Citrus bergamia*,[@bib22] *Woodfordia fruticosa*,[@bib23] and *Artocarpus lakoocha*[@bib9] showing that Gram negative bacteria were more susceptible to some plant extracts than Gram positive. This contrasted to previous studies showed that plant extracts were more active against Gram positive bacteria than Gram negative bacteria.[@bib24], [@bib25] The Gram negative bacteria are considered to be more resistant due to their outer membrane acting as a barrier to many environmental substances including antimicrobial substances. Moreover, they could stimulate the membrane-associated mechanisms of resistance via the expression of efflux pumps to control the antibacterial agents.[@bib26], [@bib27]

Deshpande and Kadam[@bib21] reported that 4-chromanol was a predominant compound in *P. betle* leaves aqueous extract, which responded for antibacterial activity. Our previously study demonstrated that the major constituents of *P. betle* leaves extract were 4-chromanol (62.33%) and eugenol (17.10%) in GC-MS analysis, and the 4-chromanol showed good anticandidal activities.[@bib15] In this study, the 4-chromanol also exhibited the strong antibacterial activity by observing a clear inhibition zone against oral pathogens in the TLC-bioautography assay. Thus, it indicated that the 4-chromanol could overcome the barrier and membrane-associated resistance of Gram negative bacterial membrane.

5. Conclusion {#sec5}
=============

This study suggested that the ethanol extract of *P. betle* leaves is a potential source of natural antibacterial and antibiofilm agents. The major constituents of *P. betle* leaves extract was 4-chromanol exhibiting a good antibacterial and antibiofilm properties that may be used for oral infectious diseases. For further study, the mechanisms of antibacterial activity of 4-chromanol should be investigated in more detail as well as its activity *in vivo*.
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![Time-kill curves of *S. mutans* ATCC 25175 (a) and *A. actinomycetemcomitans* ATCC 33384 (b) at different concentrations of *P. betle* extract: 0 × MIC (▵), 1 × MIC (▾), 2 × MIC (○), and 4 × MIC (●); 0.1% (w/v) CHX (■); CFU, Colony Forming Units.](gr1){#fig1}

![Inhibition (a) and eracdication (b) of biofilm formation of *S. mutans* ATCC 25175 (□) and *A. actinomycetemcomitans* ATCC 33384 (■) by *P. betle* leaves extract at various concentrations, 0.1% (w/v) CHX was used as control. Error bars indicate standard deviations; n = 6.](gr2){#fig2}

![HPLC chromatograms of the standards; 4-chromanol and eugenol (a), *P. betle* leaf extract (b), and the mixture of the standards and *P. betle* extract (c).](gr3){#fig3}

![TLC fingerprinting (a) and TLC-bioautography against *S. mutans* ATCC 25175 (b) of *P. betle* leaves extract.](gr4){#fig4}

###### 

Plants and susceptibility of oral microorganisms.

  Scientific name                 Voucher specimen no.   Used part   Antibacterial activity of microorganisms                               
  ------------------------------- ---------------------- ----------- ------------------------------------------ ---- ---- ----- ----- ----- -----
  *Mentha cordifolia* Opiz.       SKP 095130301          Leaf        ++                                         \+   \+   −     −     \+    \+
  *Ocimum africanum* L.           SKP 095150201          Aerial      \+                                         \+   \+   −     −     .     \+
  *Ocimum basilicum* Lour.        SKP 095150101          Aerial      \+                                         \+   \+   −     −     −     −
  *Ocimum sanctum* L.             SKP 095151901          Aerial      \+                                         \+   \+   −     −     −     −
  *Piper betle* L.                SKP 146160201          Leaf        ++                                         ++   ++   +++   +++   +++   +++
  *Piper chaba* Hunter            SKP 146160301          Fruit       \+                                         −    −    −     −     −     \+
  *Piper nigrum* L.               SKP 146161401          Fruit       \+                                         −    −    −     −     −     \+
  *Piper sarmentosum* Roxb.       SKP 146161906          Leaf        \+                                         −    −    −     −     −     ++
  *Alpinia galanga* (L.) Willd.   SKP 206010701          Rhizome     −                                          −    −    −     \+    ++    ++
  *Curcuma longa* L.              SKP 206031201          Rhizome     \+                                         −    −    −     \+    −     ++
  *Curcuma zedoaria* Roscoe       SKP 206032601          Rhizome     −                                          −    −    −     \+    −     ++
  *Zingiber officinale* Roscoe    SKP 206261501          Rhizome     ++                                         −    −    \+    −     −     ++

+, 0 \< zone \< 10 mm; ++, 10 ≤ zone \< 20 mm; +++, 20 ≤ zone; −, absence of inhibition zone.

###### 

MIC and MBC of *P. betle* extracts against oral microorganisms.

  Microorganisms                          Concentration of extract (mg/mL)   
  --------------------------------------- ---------------------------------- -------------
  Gram positive bacteria:                                                    
  *E. faecalis* ATCC 19433                5.21 ± 1.80                        8.33 ± 3.61
  *L. fermentum* ATCC 14931               4.17 ± 1.80                        8.33 ± 3.61
  *L. salivarius* ATCC 11741              4.17 ± 1.80                        8.33 ± 3.61
  *S. sobrinus* ATCC 33478                1.56 ± 0.00                        3.17 ± 1.80
  *S. mutans* ATCC 25175                  1.56 ± 0.00                        3.17 ± 1.80
  Gram negative bacteria:                                                    
  *A. actinomycetemcomitans* ATCC 33384   1.04 ± 0.45                        2.08 ± 0.90
  *F. nucleatum* ATCC 25586               1.30 ± 0.45                        2.08 ± 0.90

MIC -- the minimum inhibitory concentration.

MBC -- the minimum bactericidal concentration.
